ea0037ep53 | Adrenal cortex | ECE2015
Morelli Valentina
, Messina Erika
, Mendola Marco
, Cairoli Elisa
, Ambrosi Bruno
, Cannavo Salvatore
, Chiodini Iacopo
, Spada Anna
Introduction: The classical replacement therapy for hypoadrenalism may expose patients to non-physiologic glucocorticoids levels with negative metabolic consequences. Up to now, one study demonstrated that, as compared to the classical treatment, a modified-release hydrocortisone (MRH), improves weight, blood pressure, glycaemic control and QoL in a 3-month follow-up period. Few data are available on the long-term persistence of these benefits.Design/met...